Cover Image
Market Research Report
Product code 
1031722

Biopsy Guidance System Market Research Report by Product, by Application, by End-use, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 192 Pages | Delivery time: 1-2 business days

Price

Back to Top
Biopsy Guidance System Market Research Report by Product, by Application, by End-use, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published: October 5, 2021
360iResearch LLP
Content info: 192 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global Biopsy Guidance System Market size was estimated at USD 934.54 million in 2020 and expected to reach USD 988.93 million in 2021, at a CAGR 6.15% to reach USD 1,337.60 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Biopsy Guidance System to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Product, the market was studied across MRI Guided Biopsy, Stereotactic Guided Biopsy, and Ultrasound Guided Biopsy.
  • Based on Application, the market was studied across Brain Biopsy and Breast Biopsy.
  • Based on End-use, the market was studied across Diagnostic Centers, Hospitals, Research and Academic Institutes, and Specialty Clinics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopsy Guidance System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopsy Guidance System Market, including ARGON MEDICAL, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Cook Medical, Fujifilm Holdings Corporation, Gallini Medical, Hologic, Inc., INRAD Inc., Medtronic PLC, Olympus Corporation, PLANMED OY, and Siemens Healthineers.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Biopsy Guidance System Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopsy Guidance System Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopsy Guidance System Market?
  • 4. What is the competitive strategic window for opportunities in the Global Biopsy Guidance System Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Biopsy Guidance System Market?
  • 6. What is the market share of the leading vendors in the Global Biopsy Guidance System Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Biopsy Guidance System Market?
Table of Contents
Product Code: MRR-C271879142D2

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Increasing prevalence of cancer
    • 5.2.2. Rising preference for minimally invasive biopsy treatments
    • 5.2.3. Increasing government and non-government initiatives related to the biopsy guidance
  • 5.3. Restraints
    • 5.3.1. High cost associated with biopsy guidance system
  • 5.4. Opportunities
    • 5.4.1. Continuous technological advancements such as robot-assisted biopsy guidance systems, needle-based biopsy guns
    • 5.4.2. Rising awareness of breast cancer treatment and diagnosis
  • 5.5. Challenges
    • 5.5.1. Complications associated with imaging systems

6. Biopsy Guidance System Market, by Product

  • 6.1. Introduction
  • 6.2. MRI Guided Biopsy
  • 6.3. Stereotactic Guided Biopsy
  • 6.4. Ultrasound Guided Biopsy

7. Biopsy Guidance System Market, by Application

  • 7.1. Introduction
  • 7.2. Brain Biopsy
  • 7.3. Breast Biopsy

8. Biopsy Guidance System Market, by End-use

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals
  • 8.4. Research and Academic Institutes
  • 8.5. Specialty Clinics

9. Americas Biopsy Guidance System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopsy Guidance System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa Biopsy Guidance System Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. ARGON MEDICAL
  • 13.2. B. Braun Melsungen AG
  • 13.3. Becton, Dickinson and Company
  • 13.4. Boston Scientific Corporation
  • 13.5. C. R. Bard, Inc.
  • 13.6. Cardinal Health, Inc.
  • 13.7. Cook Medical
  • 13.8. Fujifilm Holdings Corporation
  • 13.9. Gallini Medical
  • 13.10. Hologic, Inc.
  • 13.11. INRAD Inc.
  • 13.12. Medtronic PLC
  • 13.13. Olympus Corporation
  • 13.14. PLANMED OY
  • 13.15. Siemens Healthineers

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: MARKET DYNAMICS
  • FIGURE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 14. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 16. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2026
  • FIGURE 23. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 32. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 33. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 34. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 35. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 36. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 37. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 38. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 39. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 40. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 41. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 42. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 43. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 44. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 45. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 46. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 47. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 48. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 49. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 50. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 57. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 58. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 59. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 60. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 61. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: FPNV POSITIONING MATRIX
  • FIGURE 62. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOPSY GUIDANCE SYSTEM MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY MRI GUIDED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY STEREOTACTIC GUIDED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY ULTRASOUND GUIDED BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BRAIN BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY BREAST BIOPSY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY END-USE, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 15. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 16. AMERICAS BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 17. ARGENTINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 18. BRAZIL BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 19. CANADA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 20. MEXICO BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 21. UNITED STATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 22. ASIA-PACIFIC BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 23. AUSTRALIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 24. CHINA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 25. INDIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. INDONESIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. JAPAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. MALAYSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. PHILIPPINES BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. SINGAPORE BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. SOUTH KOREA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. TAIWAN BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. THAILAND BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. EUROPE, MIDDLE EAST & AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. FRANCE BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. GERMANY BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. ITALY BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. NETHERLANDS BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. QATAR BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. RUSSIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. SAUDI ARABIA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. SOUTH AFRICA BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. SPAIN BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. UNITED ARAB EMIRATES BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 45. UNITED KINGDOM BIOPSY GUIDANCE SYSTEM MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 46. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: SCORES
  • TABLE 47. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: BUSINESS STRATEGY
  • TABLE 48. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: PRODUCT SATISFACTION
  • TABLE 49. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: RANKING
  • TABLE 50. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 51. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: MERGER & ACQUISITION
  • TABLE 52. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 53. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 54. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: INVESTMENT & FUNDING
  • TABLE 55. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 56. GLOBAL BIOPSY GUIDANCE SYSTEM MARKET: LICENSE & PRICING